Kelonia Therapeutics jobs and careers
Cambridge, England, United Kingdom
About Kelonia Therapeutics
Kelona is revolutionizing gene delivery to expand the impact of genetic medicines. Their goal is to develop a new wave of accessible genetic medicines that will transform the lives of patients suffering from a broad range of conditions.
Founded in 2017 by Kevin Friedman, Michael Birnbaum, Michael Fischbach and Molly Perkins.
- Founded
- 2017
- Employees
- 11 to 50
- Total funding
- $50M
- Headquarters
- Cambridge
Leadership
The top of Kelonia Therapeutics's org chart, with how many people report into each leader.
Kevin Friedman
Chief Executive Officer
43 reports
Laura Sandler
SVP, Strategic Operations
17 reports
Sarah Tannehill-Gregg
Vice President, Preclinical Development
10 reports
M. Travis Quigley
SVP. Clinical Development, Technical Development Operations, and Program and Alliance Management
9 reports
Michael McDonald
Senior Vice President, Head of Intellectual Property and Legal Affairs
1 report
James Rottman
Senior Vice President and Head of Research
1 report
Charlene Stern
Chief Business Officer
Board
Bob More
Board Member
Bryan Roberts
Board Member
Michael Birnbaum
Board Member
Jobs at Kelonia Therapeutics
No open positions right now. Explore more companies on TheJobsMap.